Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof

Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof

US Patent 12134610 · Granted Nov 5, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bolter miner and tunneling system2025
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2025
Bond-selective intensity diffraction tomography and uses thereof2024
Somatostatin modulators and uses thereof2023
Gonadotropin-releasing hormone receptor antagonists and methods relating thereto2023
Substituted benzoxazole and benzofuran compounds as PDE7 inhibitors2023
Somatostatin modulators and uses thereof2023
Somatostatin modulators and uses thereof2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2023
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof2023
Tumor targeting polypeptide and method of use thereof2023
Nonpeptide somatostatin type 5 receptor agonists and uses thereof2022